flurbiprofen has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lozanski, G | 1 |
Ballou, SP | 1 |
Kushner, I | 1 |
1 other study available for flurbiprofen and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Effect of flurbiprofen on cytokine production by human monocytes and U-937 and THP-1 cell lines.
Topics: Cells, Cultured; Cytokines; Enzyme-Linked Immunosorbent Assay; Flurbiprofen; Humans; Interleukin-1; | 1992 |